3D細胞培養市場：技術別、用途別、エンドユーザー別、地域別

世界の3D細胞培養市場は、2023年に48億9,000万米ドルと推定され、予測期間（2023-2030年）に23.4%のCAGRを示すと予測されています。

図1.3D細胞培養の世界市場シェア（％）、技術別、2023年

3D細胞培養とは、生物学的細胞が3次元的に増殖したり、周囲環境と相互作用したりできるように人工的に作られた環境のことです。2次元環境（ペトリ皿など）とは異なり、3D細胞培養ではin vitroの細胞は生体内と同様にあらゆる方向に成長することができます。3D細胞培養は、支持足場があってもなくても培養できます。通常、バイオリアクターと呼ばれる小さなカプセルの中で培養され、その中で細胞はスフェロイド（3D細胞コロニー）へと成長します。3Dスフェロイドは、細胞間のコミュニケーションや細胞外マトリックスの発達という点で、より生体内組織に近いです。これらのマトリックスにより、細胞はスフェロイド内で、生きた組織での細胞の動きと同じように動くことができます。3D細胞培養は、数十年前から研究に使用されており、医薬化合物に対する細胞の反応を評価するために使用されるin vitro疾患モデルにも応用されています。また、COVID-19との闘いを支援する多用途で生物学的に関連性の高い研究モデルとしても、ますます人気が高まっています。

市場力学

主な企業は、先進的な3D細胞培養技術、革新的な生体材料、および課題に対処し、より優れた性能を提供する培養プラットフォームを開発するために、研究開発に多大なリソースを割いています。

さらに、特殊な足場、培養プレート、バイオリアクター、マイクロ流体デバイスなど、3D細胞培養のための製品がメーカー各社から絶えず市場に投入されており、これが市場をさらに牽引しています。

本調査の主な特徴

• 本レポートは、世界の3D細胞培養市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模および年間平均成長率（CAGR%）を提供しています。
• また、さまざまなセグメントにわたる潜在的な成長収益機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の発売や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 世界の3D細胞培養市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
• 世界の3D細胞培養市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界の3D細胞培養市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 仮定
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 市場動向
• USFDAの規制シナリオ
• 最近の製品発売
• PEST分析
• 技術の進歩
• 合併と買収
• 主なハイライト

第4章 世界の3D細胞培養市場-COVID-19の影響分析

• 経済的影響
• COVID-19の疫学
• 需要と供給への影響

第5章 世界の3D細胞培養市場、技術別、2018～2030年

• 細胞外マトリックス/足場
• バイオリアクター
• ゲル
• 非足場プラットフォーム
• マイクロチップ

第6章 世界の3D細胞培養市場、用途別、2018～2030年

• 研究
• 創薬
• 組織工学
• 臨床応用
• 幹細胞生物学

第7章 世界の3D細胞培養市場、エンドユーザー別、2018～2030年

• 研究ラボ・機関
• バイオ医薬品産業
• 病院・診断センター
• その他

第8章 世界の3D細胞培養市場、地域別、2018～2030年

• 北米
• 米国
• カナダ
• 欧州
• 英国
• ドイツ
• イタリア
• フランス
• スペイン
• ロシア
• その他欧州
• アジア太平洋地域
• 中国
• インド
• 日本
• ASEAN
• オーストラリア
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• ブラジル
• メキシコ
• アルゼンチン
• その他ラテンアメリカ
• 中東
• GCC
• イスラエル
• その他中東
• アフリカ
• 北アフリカ
• 中央アフリカ
• 南アフリカ

第9章 競合情勢

• 企業プロファイル
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc.

第10章 セクション

• 参考文献
• 調査手法

The Global 3d Cell Culture Market is estimated to be valued at US$ 4.89 Billion in 2023 and is expected to exhibit a CAGR of 23.4% during the forecast period (2023-2030).

Figure 1. Global 3D Cell Culture Market Share (%), By Technology, 2023

A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g., a Petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. 3D cell cultures can be grown with or without a supporting scaffold. They are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. 3D spheroids more closely resemble in vivo tissue in terms of cellular communication and the development of extracellular matrices. These matrices help the cells to be able to move within their spheroid similar to the way cells would move in a living tissue. 3D cell cultures have been used in research for several decades and have been applied to in vitro disease models used to evaluate cellular responses to pharmaceutical compounds. They are also becoming increasingly popular as versatile and biologically relevant research models to support the fight against COVID-19.

Market Dynamics

Key companies are allocating significant resources in research and development to create advanced 3D cell culture technologies, innovative biomaterials, and culture platforms that address challenges and offer better performance. For instance, from April 8 to April 13, 2022 several emerging trends in cancer therapy were presented at the American Association for Cancer Research (AACR) 2022 Annual Meeting, and the U.K.'s Wellcome Sanger Institute summarized five key issues: early diagnosis in the pre-cancer stage; targeting the microenvironment; equity and representation from underrepresented populations; novel biomarker evaluation; and personalized therapeutics. Each issue pointed to cancer models using 3D cell culture as a solution.

Moreover, products for 3D cell culture, such as specialized scaffolds, culture plates, bioreactors, and microfluidic devices, are constantly being introduced to the market by manufacturers which is driving the market further. For instance, in December 2020, eNuvio, a company which designs and produces new cutting-edge tools for the life science research, drug discovery, and safety assessment markets, Montreal, Canada, announced the release of the first completely reusable 3D cell culture microplate on the market: the EB-Plate.

Key features of the study:

• This report provides an in-depth analysis of the global 3D cell culture market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential growth revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global 3D cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global 3D cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D cell culture market

Detailed Segmentation:

• By Technology:
  • Extracellular Matrices or Scaffolds
  • Bioreactors
  • Gels
  • Scaffold-free Platforms
  • Microchips
• By Application:
  • Research
  • Drug Discovery
  • Tissue Engineering
  • Clinical Applications
  • Stem Cell Biology
• By End User:
  • Research Labs & Institutes
  • Biopharmaceutical Industry
  • Hospitals And Diagnostic Centers
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• USFDA Regulatory Scenario
• Recent Product Launches
• Pest Analysis
• Technological Advancements
• Mergers & Acquisitions
• Key Highlights

4. Global 3D Cell Culture Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global 3D Cell Culture Market, By Technology, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Extracellular Matrices or Scaffolds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Bioreactors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Scaffold-free Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Microchips
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

6. Global 3D Cell Culture Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Clinical Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Stem Cell Biology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

7. Global 3D Cell Culture Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Research Labs & Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Biopharmaceutical Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Hospitals And Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global 3D Cell Culture Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • Becton, Dickinson and Company
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Thermo Fisher Scientific Inc
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc.

10. Section

• References
• Research Methodology
• About us and Sales Contact